35 related articles for article (PubMed ID: 35046300)
1. A patient alive without disease 32 months after conversion surgery following lenvatinib treatment for hepatocellular carcinoma with a tumor thrombus originating in the middle hepatic vein and reaching the right atrium via the suprahepatic vena cava: a case report.
Gyoda Y; Ichida H; Kawano F; Takeda Y; Yoshioka R; Imamura H; Mise Y; Fukumura Y; Saiura A
Clin J Gastroenterol; 2024 Apr; 17(2):311-318. PubMed ID: 38277091
[TBL] [Abstract][Full Text] [Related]
2. Clinical and biomarker analyses of hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 inhibitor for patients with advanced intrahepatic cholangiocarcinoma.
Huang Y; Du Z; Kan A; He M; Li H; Lai Z; Wen D; Huang L; Li Q; Xu L; Shi M
Front Immunol; 2024; 15():1260191. PubMed ID: 38384459
[TBL] [Abstract][Full Text] [Related]
3. Unexpected response to systemic chemotherapy in case of primarily nonresectable advanced disseminated intrahepatic cholangiocarcinoma.
Slupski MW; Szczylik C; Jasinski MK
World J Surg Oncol; 2007 Mar; 5():36. PubMed ID: 17376238
[TBL] [Abstract][Full Text] [Related]
4. A case of hepatocellular carcinoma with pseudoaneurysm formation upon lenvatinib administration.
Yano R; Hirooka M; Nakamura Y; Imai Y; Koizumi Y; Watanabe T; Yoshida O; Tokumoto Y; Abe M; Hiasa Y
Clin J Gastroenterol; 2024 Apr; 17(2):319-326. PubMed ID: 38281290
[TBL] [Abstract][Full Text] [Related]
5. Significant response to pembrolizumab plus lenvatinib in Epstein-Barr-virus-associated intrahepatic cholangiocarcinoma: a case report.
Li L; Yu D; Yang J; Zhang F; Zhang D; Lin Z; Zhai M; Wang J; Zhang T; Zhao L
Cancer Biol Ther; 2024 Dec; 25(1):2338644. PubMed ID: 38650446
[TBL] [Abstract][Full Text] [Related]
6. A case of conversion therapy for hepatocellular carcinoma with bile duct tumor thrombus.
Wu JL; Peng P; Hu ZM; Sun Q
Asian J Surg; 2024 May; ():. PubMed ID: 38714402
[No Abstract] [Full Text] [Related]
7. Indications for and limitations of portal vein embolization before major hepatic resection for hepatobiliary malignancy.
Denys A; Madoff DC; Doenz F; Schneider F; Gillet M; Vauthey JN; Chevallier P
Surg Oncol Clin N Am; 2002 Oct; 11(4):955-68. PubMed ID: 12607582
[TBL] [Abstract][Full Text] [Related]
8. Anatomical liver segmentectomy 2 for combined hepatocellular carcinoma and cholangiocarcinoma with tumor thrombus in segment 2 portal branch.
Ishii H; Kobayashi T; Kudou M; Nishimura M; Toma A; Nakamura K; Mazaki T; Itoh T
World J Surg Oncol; 2012 Jan; 10():22. PubMed ID: 22273493
[TBL] [Abstract][Full Text] [Related]
9. [A Case of Intrahepatic Cholangiocarcinoma with Tumor Thrombus in the Left Portal Branch].
Yokota Y; Tomimaru Y; Noguchi K; Nagase H; Ogino T; Hirota M; Oshima K; Tanida T; Noura S; Kawase T; Imamura H; Iwazawa T; Akagi K; Dono K
Gan To Kagaku Ryoho; 2018 Dec; 45(13):2205-2207. PubMed ID: 30692332
[TBL] [Abstract][Full Text] [Related]
10. [Synchronous Double Primary Non-B, and Non-C Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma-A Case Report].
Tsukamoto T; Kodai S; Nobori C; Okazaki Y; Nanbara M; Edagawa E; Mori Y; Kanazawa A; Nishiyama T; Kunimoto T; Kaizaki R; Inoue T; Takatsuka S; Nishiguchi Y
Gan To Kagaku Ryoho; 2022 Apr; 49(4):486-488. PubMed ID: 35444143
[TBL] [Abstract][Full Text] [Related]
11. [A case of surgical resection of a combined hepatocellular and cholangiocarcinoma after transarterial chemoembolization].
Yakoshi Y; Toyoki Y; Ishido K; Kudo D; Kimura N; Wakiya T; Hakamada K
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1798-800. PubMed ID: 24393926
[TBL] [Abstract][Full Text] [Related]
12. Significant response to anti-PD-1 based immunotherapy plus lenvatinib for recurrent intrahepatic cholangiocarcinoma with bone metastasis: A case report and literature review.
Chen WX; Li GX; Hu ZN; Zhu P; Zhang BX; Ding ZY
Medicine (Baltimore); 2019 Nov; 98(45):e17832. PubMed ID: 31702638
[TBL] [Abstract][Full Text] [Related]
13. [A Case of Combined Hepatocellular Carcinoma and Cholangiocarcinoma with Multidisciplinary Treatment Including Lenvatinib].
Furuya K; Ioka T; Shindo Y; Tokumitsu Y; Matsui H; Matsukuma S; Nakajima M; Yamada K; Watanabe Y; Tomochika S; Yoshida S; Iida M; Suzuki N; Takeda S; Nagano H
Gan To Kagaku Ryoho; 2021 Dec; 48(13):1694-1696. PubMed ID: 35046300
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
